{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:31:37Z","timestamp":1790811097365,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151330","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T20:19:05Z","timestamp":1458159545000},"page":"e0151330","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Long-Term Toxicity of 213Bi-Labelled BSA in Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"La\u00ebtitia","family":"Dorso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Bigot-Corbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Abadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bruchertseifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Maurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ch\u00e9rel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Davodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s002590100484","article-title":"General aspects of the cellular response to low- and high-LET radiation","volume":"28","author":"JP Pouget","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/cbr.2009.0628","article-title":"Glomerular filtration rate after alpha-radioimmunotherapy with 211At-MX35-F(ab')2: a long-term study of renal function in nude mice","volume":"24","author":"T Back","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1088\/0031-9155\/56\/3\/012","article-title":"Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody","volume":"56","author":"J Schwartz","year":"2011","journal-title":"Phys Med Biol"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1681\/ASN.2004110945","article-title":"Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters","volume":"16","author":"JS Jaggi","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4161\/cbt.6.6.4097","article-title":"Pharmacokinetics and toxicity of (213)Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer","volume":"6","author":"EY Song","year":"2007","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"ref6","first-page":"2635","article-title":"High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model","volume":"59","author":"TM Behr","year":"1999","journal-title":"Cancer Res"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-10-1186","article-title":"Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)","volume":"71","author":"D Wild","year":"2011","journal-title":"Cancer Res"},{"issue":"3 Pt 1","key":"ref8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/1078-0432.CCR-05-1264","article-title":"213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model","volume":"12","author":"JP Norenberg","year":"2006","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00259-011-2023-6","article-title":"Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis","volume":"39","author":"M Essler","year":"2012","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"1\u20132","key":"ref10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.bjc.6690337","article-title":"Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi","volume":"80","author":"SJ Kennel","year":"1999","journal-title":"Br J Cancer"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/0008-5472.CAN-08-4363","article-title":"Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211","volume":"69","author":"H Nakamae","year":"2009","journal-title":"Cancer Res"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/1078-0432.CCR-03-0171","article-title":"Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N\u2034-tetraacetic acid-biotin","volume":"10","author":"Z Yao","year":"2004","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0008-6363(96)00064-8","article-title":"Transport of macromolecules through microvascular walls","volume":"32","author":"CC Michel","year":"1996","journal-title":"Cardiovascular research"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2040-2384-2-14","article-title":"Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability","volume":"2","author":"H Sarin","year":"2010","journal-title":"Journal of angiogenesis research"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0969-8051(94)00126-5","article-title":"A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies","volume":"22","author":"TK Nikula","year":"1995","journal-title":"Nucl Med Biol"},{"issue":"19","key":"ref16","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1021\/ac0580114","article-title":"Production of Ac-225 from Th-229 for targeted alpha therapy","volume":"77","author":"C Apostolidis","year":"2005","journal-title":"Anal Chem"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2967\/jnumed.112.111997","article-title":"213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma","volume":"54","author":"M Cherel","year":"2013","journal-title":"J Nucl Med"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0006-291X(78)91322-0","article-title":"Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril","volume":"80","author":"PJ Fraker","year":"1978","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0041-008X(86)90384-4","article-title":"Disposition of metals in rats: a comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals","volume":"85","author":"Z Gregus","year":"1986","journal-title":"Toxicology and applied pharmacology"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2967\/jnumed.106.035337","article-title":"Spatial distribution of blood vessels and CD34+ hematopoietic stem and progenitor cells within the marrow cavities of human cancellous bone","volume":"48","author":"CJ Watchman","year":"2007","journal-title":"J Nucl Med"},{"issue":"7 Suppl","key":"ref21","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"B Thoolen","year":"2010","journal-title":"Toxicol Pathol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semradonc.2006.11.009","article-title":"Normal tissue tolerance dose metrics for radiation therapy of major organs","volume":"17","author":"MT Milano","year":"2007","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/108497802760363204","article-title":"Structure and function of bone marrow hemopoiesis: mechanisms of response to ionizing radiation exposure","volume":"17","author":"TM Fliedner","year":"2002","journal-title":"Cancer Biother Radiopharm"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/geronj\/37.5.540","article-title":"Changes with age in renal function and morphology in C57BL\/6, CBA\/HT6, and B6CBAF1 mice","volume":"37","author":"H Hackbarth","year":"1982","journal-title":"Journal of gerontology"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"F1265","DOI":"10.1152\/ajprenal.00543.2007","article-title":"The impact of aging on kidney repair","volume":"294","author":"R Schmitt","year":"2008","journal-title":"American journal of physiology Renal physiology"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/blood-2001-12-0322","article-title":"Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts","volume":"100","author":"BM Sandmaier","year":"2002","journal-title":"Blood"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1182\/blood-2002-12-3867","article-title":"Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation","volume":"101","author":"WA Bethge","year":"2003","journal-title":"Blood"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V100.4.1233.h81602001233_1233_1239","article-title":"Targeted alpha particle immunotherapy for myeloid leukemia","volume":"100","author":"JG Jurcic","year":"2002","journal-title":"Blood"},{"issue":"21","key":"ref29","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1158\/1078-0432.CCR-10-0382","article-title":"Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia","volume":"16","author":"TL Rosenblat","year":"2010","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"11","key":"ref30","first-page":"1935","article-title":"Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia","volume":"40","author":"G Sgouros","year":"1999","journal-title":"J Nucl Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T07:05:22Z","timestamp":1600326322000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151330"}},"subtitle":[],"editor":[{"given":"Bing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]}}}